M

Milestone Scientific Inc
AMEX:MLSS

Watchlist Manager
Milestone Scientific Inc
AMEX:MLSS
Watchlist
Price: 1.08 USD 17.39% Market Closed
Market Cap: 84.1m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MLSS Price Targets Summary
Milestone Scientific Inc

Wall Street analysts forecast MLSS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MLSS is 2.17 USD with a low forecast of 1.26 USD and a high forecast of 3.15 USD.

MLSS Lowest Forecast
Wall Street Target
1.26 USD
17% Upside
MLSS Average Forecast
Wall Street Target
2.17 USD
101% Upside
MLSS Highest Forecast
Wall Street Target
3.15 USD
192% Upside
Lowest
Price Target
1.26 USD
17% Upside
Average
Price Target
2.17 USD
101% Upside
Highest
Price Target
3.15 USD
192% Upside
Milestone Scientific Inc Competitors:
Price Targets
SN
Smith & Nephew PLC
17% Upside
SRDX
Surmodics Inc
57% Upside
M
MODU
Modulight Oyj
22% Upside
SHL
Siemens Healthineers AG
34% Upside
SN
Smith & Nephew PLC
17% Upside
SRDX
Surmodics Inc
57% Upside
M
MODU
Modulight Oyj
22% Upside
SHL
Siemens Healthineers AG
34% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
31% Downside
OWLT
Owlet Inc
167% Upside

Revenue
Forecast

Revenue Estimate
Milestone Scientific Inc

For the last 8 years the compound annual growth rate for Milestone Scientific Inc's revenue is -2%. The projected CAGR for the next 2 years is 25%.

-2%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Milestone Scientific Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Milestone Scientific Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

See Also

Summary
MLSS intrinsic value, competitors valuation, and company profile.
DCF Valuation
MLSS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MLSS stock valuation using valuation multiples.
Wall Street Estimates
MLSS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MLSS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MLSS's stock price target?
Price Target
2.17 USD

According to Wall Street analysts, the average 1-year price target for MLSS is 2.17 USD with a low forecast of 1.26 USD and a high forecast of 3.15 USD.

What is Milestone Scientific Inc's Revenue forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Milestone Scientific Inc's revenue is -2%. The projected CAGR for the next 2 years is 25%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.